KMDA · Kamada Ltd

25.50

ILS

1.40 (5.81%)

24/08/2026 12:00:00 AM

Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

ILS1.39B

18.70

EV/EBITDA

7.9

DIV Yield

3.4%

Payout Ratio

64%

MQV Rating

5Very Weak

As at 24/08/2026 12:00:00 AM

Price Chart

Description

Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. It operates through the Proprietary Products and Distribution segments. The Proprietary Products segment refers to specialty plasma therapies and normal source plasma ("NSP"). The Distribution segment focuses on the commercialization of in-licensed third-party biopharmaceutical products. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Rehovot, Israel.

All-Companies
All-Consensus
Consensus Cheap
EMA 125 Breakup
HALO 200
HALO All
HALO Consensus Value
HALO Small
HALO Value
Near Resistance

Key Fundamentals

EPS 3 yr Growth

-776.60%

EBITDA Margin

22.80%

Operating Cashflow

$25m

Free Cash Flow Return

9.40%

ROIC

7.50%

Interest Coverage

47.60

Quick Ratio

2.30

Performance

52 weeks range

Low 19.56 - 28.9

Trade Value (12mth)

US$151,207.00

1 week

11.11%

1 month

11.57%

YTD

6.54%

1 year

-7.24%

All time high

62.00

Additional Data

Shares Outstanding (Fully Diluted)

58m

HALO Sector

Healthcare

Next Company Report Date

17-Mar-27

Next Ex Dividend Date

27-Aug-26

Next Dividend Pay Date

17-Sep-26

Reporting Currency

USD

Short Sell (% of issue)

0.00

Consensus

Unlock full consensus

Consensus score

/10

Recommendation

Buy

Target price

Deviation

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

Halo Model

Mqv

Very Weak

Garp

Weak

Mqv Small

Very Weak

Momentum

Price

Neutral

Earnings

Very Weak

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Weak

Balance Sheet

Very Weak

Valuation

Unlock full dataset

Value

Consensus

Yield

News & Announcements

No announcements available.

Key Stakeholders

Name	Title
First Israel Mezzanine Investors Ltd.	Private Company
Leon Y. Recanati	Individual
David Tsur	Individual
Amir London	Individual
Orit Pinchuk	Individual